NCT01203748 - Substrate and Trigger Ablation for Reduction of Atrial Fibrillation Trial - Star AF II Study | Biotech Hunter

Enrollment

589

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions

Atrial Fibrillation

Interventions

PROCEDURE

PVI + Lines ablation

Pulmonary vein antrum isolation with additional linear ablation (mitral line and roof line)

PROCEDURE

PVI

Pulmonary vein antrum isolation

PROCEDURE

PVI + CFE ablation

Pulmonary vein antrum isolation with additional complex fractionated electrogram ablation

Trial Locations (2)

St. Andrews War Memorial Hospital, Brisbane

Southlake Regional Health Centre, Newmarket